Jing Li
lijing@simm.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 2005-03--2008-09 PhD: Zhejiang University
  • 2001-09--2004-06 Master's Degree: Hebei Normal University
  • 1997-09--2001-06 Bachelor's Degree: Hebei Normal University
  • 2019-10~Present - Chinese Academy of Sciences Shanghai Institute of Materia Medica - Researcher
  • 2017-01~2017-09 - University of California, San Diego - Visiting Scholar
  • 2012-10~2019-09 - Chinese Academy of Sciences Shanghai Institute of Materia Medica - Associate Researcher
  • 2008-10~2012-09 - Chinese Academy of Sciences Shanghai Institute of Materia Medica - Assistant Researcher
G protein-coupled receptors and diseases
  • Palladium(II)-Catalyzed Tandem C(sp2)-H Arylation and Cyclization for the Construction of Natural Product-Like Polycyclic Fused ortho-Quinone Scaffolds., 4th Author, 2024
  • Late-Stage Functionalization for the Divergent Synthesis of Podophyllotoxin Derivatives by Rhodium Catalysis., 4th Author, 2023
  • Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol., Not mentioned, 2023
  • Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5 H88Y Mutant Mice., 12th Author, 2021
  • PD-L1 expression levels on tumor cells affect their immunosuppression activity., Not mentioned, 2019
  • Testosterone-induced Benign Prostatic Hyperplasia Rat and Dog as Facile Models to Assess Drugs Targeting Lower Urinary Tract Symptoms., Not mentioned, 2018
G Protein-Coupled Receptors Diseases Pharmacology Biochemistry Molecular Biology Drug Discovery Receptor Signaling Therapeutics Cell Biology Biomedical Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.